Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy

British Journal of Ophthalmology

Volumn 83, Issue 11, 1999, Pages 1287-1290

  Kawasaki, Aki ^a,b   Purvin, Valerie A ^a,b   Burgett, Richard A ^a  

^a MIDWEST EYE INSTITUTE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; KIDNEY FUNCTION TEST; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SMOKING;

EID: 0032732726     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.11.1287     Document Type: Article

References (14)

1. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood l997;90: 1-11.
2. The European Concerted Action Project, Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81.
3. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-27.
4. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-55.
5. Stamfer MJ, Malinow MR, Willet WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA 1992;268:877-81.
6. Heijer MD, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
7. Coull BM, Malinow MR, Beamer N, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572-6.
8. Boushey CJ, Beresford SAA, Omenn GS, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
9. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
10. Wenzler EM, Rademakers AJJM, Boers GHJ, et al. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 1993;115:162-7.
11. Biousse V, Newman NJ, Sternberg P Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystenemia. Am J Ophthalmol 1997;124:25760.
12. Loewenstein A, Winder A, Goldstein M et al. Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol 1997;124:840-1.
13. Engbersen AMT, Franken DG, Boers GHJ, et al. Thermolabile 5, 10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56: 142-50.
14. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.